87 related articles for article (PubMed ID: 27517656)
21. Dose-dependent effects of the renin inhibitor zankiren HCl after a single oral dose in mildly sodium-depleted normotensive subjects.
Ménard J; Boger RS; Moyse DM; Guyene TT; Glassman HN; Kleinert HD
Circulation; 1995 Jan; 91(2):330-8. PubMed ID: 7805235
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements.
Le Meur Y; Lorgeot V; Comte L; Szelag JC; Aldigier JC; Leroux-Robert C; Praloran V
Am J Kidney Dis; 2001 Sep; 38(3):510-7. PubMed ID: 11532682
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ
Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966
[TBL] [Abstract][Full Text] [Related]
24. Perindopril and physiologic responses to exercise.
Klug EQ; Joffe BI; Panz VR; Meyer TE; Fine BJ; Seftel HC
J Cardiovasc Pharmacol; 1994 Jun; 23(6):864-8. PubMed ID: 7523776
[TBL] [Abstract][Full Text] [Related]
25. Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations.
Comte L; Lorgeot V; Volkov L; Allegraud A; Aldigier JC; Praloran V
Eur J Clin Invest; 1997 Sep; 27(9):788-90. PubMed ID: 9352252
[TBL] [Abstract][Full Text] [Related]
26. Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.
Struthers AD; MacFadyen R; Fraser C; Robson J; Morton JJ; Junot C; Ezan E
J Am Coll Cardiol; 1999 Dec; 34(7):2072-7. PubMed ID: 10588226
[TBL] [Abstract][Full Text] [Related]
27. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
28. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
Tropeano AI; Boutouyrie P; Pannier B; Joannides R; Balkestein E; Katsahian S; Laloux B; Thuillez C; Struijker-Boudier H; Laurent S
Hypertension; 2006 Jul; 48(1):80-6. PubMed ID: 16702490
[TBL] [Abstract][Full Text] [Related]
29. Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects.
Lees KR; Reid JL
J Cardiovasc Pharmacol; 1987 Aug; 10(2):129-35. PubMed ID: 2441162
[TBL] [Abstract][Full Text] [Related]
30. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Tokita Y; Franco-Saenz R; Mulrow PJ
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of taste disturbance by losartan and perindopril in healthy volunteers.
Tsuruoka S; Wakaumi M; Araki N; Ioka T; Sugimoto K; Fujimura A
J Clin Pharmacol; 2005 Nov; 45(11):1319-23. PubMed ID: 16239366
[TBL] [Abstract][Full Text] [Related]
32. The effect of perindopril and enalapril on plasma resistin levels in normotensive patients with coronary heart disease.
Krysiak R; Sierant M; Marek B; Okopień B
Endokrynol Pol; 2010; 61(6):683-90. PubMed ID: 21104642
[TBL] [Abstract][Full Text] [Related]
33. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
Chodjania Y; Tharaux PL; Ragueneau I; Dussaule JC; Picker JL; Funck-Brentano C; Jaillon P
Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
[TBL] [Abstract][Full Text] [Related]
34. Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.
Richer C; Thuillez C; Giudicelli JF
J Cardiovasc Pharmacol; 1987 Jan; 9(1):94-102. PubMed ID: 2434802
[TBL] [Abstract][Full Text] [Related]
35. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J
J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449
[TBL] [Abstract][Full Text] [Related]
36. The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Brugts JJ; de Maat MP; Boersma E; Witteman JC; van Duijn C; Uitterlinden AG; Bertrand M; Remme W; Fox K; Ferrari R; Danser AH; Simoons ML;
Cardiovasc Drugs Ther; 2009 Apr; 23(2):171-81. PubMed ID: 19082699
[TBL] [Abstract][Full Text] [Related]
37. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
Naelten G; Liu KL; Chapuis B; Lo M
Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
[TBL] [Abstract][Full Text] [Related]
38. Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
Trongtorsak P; Morgan TO; Delbridge LM
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):213-9. PubMed ID: 14689368
[TBL] [Abstract][Full Text] [Related]
39. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.
Jackson B; Cubela RB; Johnston CI
J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
